Company Filing History:
Years Active: 1995
Title: The Innovations of Ronald C. Newbold
Introduction
Ronald C. Newbold is a notable inventor based in Bound Brook, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with practical applications.
Latest Patents
Newbold holds a patent for Avermectin derivatives. This patent describes modifications to the C-17-21-25-dioxaspirane substructure, which includes substitutions of heteratomic nucleophilic thiols at the 23,24-.alpha.-epoxide. The new C-23 and C-24 substituted avermectin derivatives are recognized for their potency as anthelmintic, insecticidal, and acaricidal agents. He has 1 patent to his name.
Career Highlights
Newbold is associated with Merck & Co., Inc., a leading global healthcare company. His work has contributed to advancements in agricultural and pharmaceutical applications, showcasing his expertise in chemical innovations.
Collaborations
One of his notable collaborators is Thomas L. Shih, with whom he has worked on various projects related to his patent.
Conclusion
Ronald C. Newbold's innovative work in the field of chemistry, particularly with Avermectin derivatives, highlights his significant contributions to science and industry. His achievements reflect the importance of research and development in creating effective solutions for real-world challenges.